These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8739474)

  • 21. Ornithine loading did not prevent induced hyperammonemia in a patient with hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
    Simell O; Mackenzie S; Clow CL; Scriver CR
    Pediatr Res; 1985 Dec; 19(12):1283-7. PubMed ID: 4080446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperornithinemia, hyperammonemia, and homocitrullinuria. A new disorder of amino acid metabolism associated with myoclonic seizures and mental retardation.
    Shih VE; Efron ML; Moser HW
    Am J Dis Child; 1969 Jan; 117(1):83-92. PubMed ID: 5782534
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hyperornithinemia-hyperammonemia-homocitrullinuria (H.H.H.) syndrome].
    Oyanagi K; Nagao M
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):185-7. PubMed ID: 9590023
    [No Abstract]   [Full Text] [Related]  

  • 24. Abnormal urinary excretion of polyamines in HHH syndrome (hyperornithinemia associated with hyperammonemia and homocitrullinuria).
    Shimizu H; Maekawa K; Eto Y
    Brain Dev; 1990; 12(5):533-5. PubMed ID: 2288388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter.
    Camacho JA; Obie C; Biery B; Goodman BK; Hu CA; Almashanu S; Steel G; Casey R; Lambert M; Mitchell GA; Valle D
    Nat Genet; 1999 Jun; 22(2):151-8. PubMed ID: 10369256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The dibasic amino acid metabolic disorders].
    Shimizu H
    Nihon Rinsho; 1992 Jul; 50(7):1555-60. PubMed ID: 1404883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new family affected by the syndrome of hyperornithinaemia, hyperammonaemia and homocitrullinuria.
    Rodes M; Ribes A; Pineda M; Alvarez L; Fabregas I; Fernandez Alvarez E; Coude FX; Grimber G
    J Inherit Metab Dis; 1987; 10(1):73-81. PubMed ID: 3106719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical analysis of decreased ornithine transport activity in the liver mitochondria from patients with hyperornithinemia, hyperammonemia and homocitrullinuria.
    Inoue I; Saheki T; Kayanuma K; Uono M; Nakajima M; Takeshita K; Koike R; Yuasa T; Miyatake T; Sakoda K
    Biochim Biophys Acta; 1988 Jan; 964(1):90-5. PubMed ID: 3334877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic variability among patients with hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome homozygous for the delF188 mutation in SLC25A15.
    Debray FG; Lambert M; Lemieux B; Soucy JF; Drouin R; Fenyves D; Dubé J; Maranda B; Laframboise R; Mitchell GA
    J Med Genet; 2008 Nov; 45(11):759-64. PubMed ID: 18978333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH) presenting with acute fulminant hepatic failure.
    Mhanni AA; Chan A; Collison M; Seifert B; Lehotay DC; Sokoro A; Huynh HQ; Greenberg CR
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):312-5. PubMed ID: 18376250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperornithinemia, hyperammonemia, and homocitrullinuria: case report and biochemical study.
    Koike R; Fujimori K; Yuasa T; Miyatake T; Inoue I; Saheki T
    Neurology; 1987 Nov; 37(11):1813-5. PubMed ID: 3670619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible pathogenetic mechanism in hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome.
    Haust MD; Gordon BA
    Birth Defects Orig Artic Ser; 1987; 23(1):17-45. PubMed ID: 3580547
    [No Abstract]   [Full Text] [Related]  

  • 33. Neonatal onset of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome with favorable outcome.
    Zammarchi E; Ciani F; Pasquini E; Buonocore G; Shih VE; Donati MA
    J Pediatr; 1997 Sep; 131(3):440-3. PubMed ID: 9329423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human and mouse SLC25A29 mitochondrial transporters rescue the deficient ornithine metabolism in fibroblasts of patients with the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome.
    Camacho JA; Rioseco-Camacho N
    Pediatr Res; 2009 Jul; 66(1):35-41. PubMed ID: 19287344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ornithine methyl ester. An unusual metabolite encountered in the urine of patients with a urea cycle disorder characterized by hyperammonemia, hyperornithinemia and homocitrullinuria.
    Gordon BA; Gatfield PD; Taller E
    Clin Biochem; 1977 Apr; 10(2):78-82. PubMed ID: 862180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of ornithine metabolism in hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome, lysinuric protein intolerance and gyrate atrophy fibroblasts.
    Botschner J; Smith DW; Simell O; Scriver CR
    J Inherit Metab Dis; 1989; 12(1):33-40. PubMed ID: 2501580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conscientious metabolic monitoring on a patient with hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome undergoing anaesthesia.
    Mühling J; Dehne MG; Fuchs M; Sablotzki A; Weiss S; Spatz J; Hempelmann G
    Amino Acids; 2001; 21(3):303-18. PubMed ID: 11764411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome.
    Camacho JA; Mardach R; Rioseco-Camacho N; Ruiz-Pesini E; Derbeneva O; Andrade D; Zaldivar F; Qu Y; Cederbaum SD
    Pediatr Res; 2006 Oct; 60(4):423-9. PubMed ID: 16940241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning and characterization of human ORNT2: a second mitochondrial ornithine transporter that can rescue a defective ORNT1 in patients with the hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, a urea cycle disorder.
    Camacho JA; Rioseco-Camacho N; Andrade D; Porter J; Kong J
    Mol Genet Metab; 2003 Aug; 79(4):257-71. PubMed ID: 12948741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrastructural changes in the mitochondria in disorders in ornithine metabolism.
    Haust MD; Gordon BA
    Pediatr Res; 1980 Dec; 14(12):1411. PubMed ID: 7208160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.